FDA approves updated COVID vaccines for seniors and at‑risk adults
TL;DR Summary
The FDA approved updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech to prevent severe disease from the dominant JN.1 lineage XFG subvariant, with approvals for adults 65+ and younger people with one or more chronic conditions; rollout is underway and insurers plan to cover the costs.
- FDA approves new COVID vaccines CIDRAP
- What to Know About New Covid Vaccines for Fall 2026 The New York Times
- FDA just approved updated covid shots. Here’s what to know as cases edge upward. The Washington Post
- What to know about the COVID and flu vaccines for 2026 kare11.com
- FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season Pharmacy Times
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
8 min
vs 9 min read
Condensed
97%
1,609 → 46 words
Want the full story? Read the original article
Read on CIDRAP